SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as traders discuss potential bullish signals, including golden cross formations and anticipation of a breakout. Community members are debating potential price targets and the strength of support levels, while some highlight Litecoin's established role in the crypto space.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending due to positive Q3 2025 earnings and high relative volume, sparking discussions of a potential short squeeze. The community highlights its low float and high short interest, drawing comparisons to recent runs of $TGL and $SMX. Some traders express caution, noting the company's history of reverse splits and share dilution.

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TREASURE GLOBAL INC ($TGL) is trending due to speculation of a potential short squeeze, drawing comparisons to recent high-flying stocks like $SMX. The community is actively discussing strategies to pressure shorts and the possibility of a large gap up, while some caution against excessive hype and potential for a pullback. Attention is focused on premarket activity and the stock's ability to sustain momentum.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending amid discussions about its AI capabilities and potential competition, with community members debating its long-term value and potential for a short squeeze. Optimism is building around upcoming earnings, while some express concern about competition from alternative platforms. The stock's recent price action and historical support levels are also driving conversation.

Confluent, Inc. engages in creating a data infrastructure platform focused on data in motion. The firm provides application architecture engagement, multi data center, security and upgrade engagement, and Amazon web services cloud deployment services. Its products include Confluent Cloud, Confluent Platform, WarpStream BYOC, Connectors, Flink, Stream Governance, and Confluent Hub. The company was founded by Edward Jay Kreps, Neha Narkhede, and Jun Rao on September 1, 2014, and is headquartered in Mountain View, CA.

Confluent Inc - Ordinary Shares Class A

Confluent Inc

Confluent is trending amid reports of a potential acquisition, with IBM being mentioned as a possible suitor. The community is discussing the potential buyout price and whether the deal will be all cash or involve shares. Bullish sentiment is fueled by the belief that Confluent's real-time data streaming platform would enhance IBM's data-to-AI pipeline.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending as traders discuss its potential for a squeeze, drawing comparisons to recent runners like TGL and SMX, especially after a positive FY2025 profit outlook announcement drove after-hours interest. The community is focused on its low float and overnight trading activity, while acknowledging the risks associated with Chinese stocks and potential pump-and-dump schemes. Some traders are setting ambitious price targets, while others urge caution due to past dilution and financial concerns.

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Solid Biosciences Inc

Solid Biosciences is trending as community members discuss the implications of recent clinical trial data and a new FDA Orphan Drug Designation. Bullish sentiment is fueled by Needham's Buy rating and a $16 price target, with some suggesting a short squeeze is possible given the stock's short float. The community is also focused on the potential of Solid's pipeline compared to competitors in the Duchenne Muscular Dystrophy space.

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

Rezolute Inc

Rezolute Inc is trending as the community anticipates Phase 3 topline data this month, with potential outcomes ranging from statistically significant results to buyout scenarios. Discussions revolve around a recent filing that revealed positive patient outcomes and a streamlined FDA protocol, interpreted by some as a strong indicator of positive data. Bullish sentiment is fueled by significant short interest and a heavy call option chain, while others analyze the implications of a recent shelf filing.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending as investors speculate about a potential partnership announcement before year-end, focusing on the possibility of a collaboration with Palantir or Lockheed Martin, which some believe could be a "game changer." Community chatter revolves around the significance of a joint press release and the potential impact on the company's market leadership in AI data training. Bearish sentiment and concerns about revenue growth are also being discussed, but bullish investors see a significant long-term upside.

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

MetaVia ($MTVA) is trending due to increased community interest surrounding its low float and potential for significant price movement, with some anticipating a substantial overnight surge. Recent news and reverse split mechanics are also driving conversation as traders look for the next big runner. The community is closely watching for price discovery and volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Keros Therapeutics (NASDAQ:KROS) Trading Up 12% - Here's Why

Keros Therapeutics (NASDAQ:KROS) Shares Up 12% - Here's Why...

Bank of America Increases Keros Therapeutics (NASDAQ:KROS) Price Target to $19.00

Bank of America raised their price target on Keros Therapeutics from $18.00 to $19.00 and gave the company a "neutral" rating in a report on Friday...

Buy These 5 Best Value Stocks to Make the Most of P/B Ratio

Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.

KROS or NVZMY: Which Is the Better Value Stock Right Now?

KROS vs. NVZMY: Which Stock Is the Better Value Option?

How Much Upside is Left in Keros Therapeutics (KROS)? Wall Street Analysts Think 34.24%

The consensus price target hints at a 34.2% upside potential for Keros Therapeutics (KROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Here's Why

Keros Therapeutics (NASDAQ:KROS) Shares Gap Down - Time to Sell...

Los Angeles Capital Management LLC Purchases New Stake in Keros Therapeutics, Inc. $KROS

Los Angeles Capital Management LLC acquired a new position in Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) in the 2nd quarter, according to the company in its most recent filing with the...

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Keros Therapeutics, Inc. $KROS

Connor Clark & Lunn Investment Management Ltd. raised its holdings in Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) by 107.4% during the 2nd quarter, according to the company in its most...

Keros Therapeutics' (KROS) Outperform Rating Reiterated at Oppenheimer

Oppenheimer restated an "outperform" rating and issued a $27.00 target price (up previously from $23.00) on shares of Keros Therapeutics in a research report on Wednesday...

5 Undervalued Stocks That Are Poised for Growth in November

Five undervalued picks -  including StoneCo and MillerKnoll - shine with strong growth prospects and low price-to-book ratios this November.

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. The company was founded in 2015 and is headquartered in Lexington, MA.

Keros Therapeutics Inc

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

Current Price	$21.69
Prev Close	$20.27
Open	$20.26
Dividend Yield	0.00%
50-Day Moving Average	$16.25
Beta	0.88
Avg. Volume	1.33M
PE Ratio	14.06

52-Week High	$72.37
52-Week Low	$9.12
Market Capitalization	$660.81M
EPS (Annual)	-$5.00
Price to Book	1.25
Revenue Per Employee	$21,005.92
Enterprise Value/EBITDA	N/A

KROS
Keros Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KROS News

KROSKeros Therapeutics Inc